Efficacy of endoscope equipped with water-jet function for hemostasis of endoscopic submucosal dissection for colorectal epitherial neoplasms: A randomized controlled open trial.

Efficacy of endoscope equipped with water-jet function for hemostasis of endoscopic submucosal dissection for colorectal epitherial neoplasms: A randomized controlled open trial. - Efficacy of water-jet endoscope for colorectal ESD.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002812

Enrollment

Registered

2009-11-30

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal epitherial neoplasm

Interventions

non water-jet group water-jet group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Intramucosal or minutes submucosal invaded (SM1) colorectal epitherial neoplasms which are larger than 20mm and smaller than 60mm.

Exclusion criteria

Exclusion criteria: 1) SM massive invaded cancer 2) Lesions which are existed on anal canal or in cecum. 3) Patients with hematological abnormality. 4) Patients with severe organ failure 5) Patients without written informed consent 6) Lesions which were thought to be difficult to resect by ESD because of unstable positioning of colonoscope. 7) Others who were thought to be unsuitable by endoscopist.

Design outcomes

Primary

Measure	Time frame
total time to hemostasis	—

Secondary

Measure	Time frame
en bloc resection rate, complete resection rate, adverse events, total procedure time, bleeding time, endoscopic device changes, Coagrasper using times, preventive hemostasis times	—

Countries

Japan

Contacts

Public ContactYoji Takechi

Osaka Medical Center for Cancer and Cardiovascular Diseases Gastrointestinal Oncology

takeuti-yo@mc.pref.osaka.jp06-6972-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026